Nav: Home

Captain T cell succeeds at OneStart competition

May 25, 2016

A big moment for cancer-fighting T-cell therapy: "Captain T Cell," a start-up project led by researchers from the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), has won this year's OneStart competition in London.

Several working groups at the MDC are researching ways of using the immune system's T cells to fight cancer in a targeted and effective manner with minimal side effects. To achieve this, they equip T cells with tumor-specific receptors that allow them to detect and specifically eliminate mutated tumor cells in the body. There is a great need for new T-cell receptors if larger groups of patients are to be treated with these personalized therapies.

The Captain T Cell start-up project aims to drive forward the transfer of this new technology from research laboratories to patient application. Captain T Cell is the initiative of MDC scientists Felix Lorenz, Elisa Kieback, Julian Clauß and Inan Edes. Using a new technology developed in the MDC laboratory of Prof. Wolfgang Uckert's working group, the scientists are working on ways to quickly and reliably identify T-cell receptors and develop a platform for their widescale application. This brings immunotherapy one step closer to the use in humans.

The group submitted their concept to OneStart -- the world's largest competition for start-ups in the field of health and life sciences. On May 16 they were selected as the winning entry from 400 international teams. This is the first time that the prize money of £100,000 has been awarded to a team from outside the U.S. or the U.K.

Captain T Cell is supported by the MDC's own Technology Transfer Office and by the SPARK Berlin program -- a mentoring network from the Berlin Institute of Health (BIH) and the Stiftung Charité that promotes application-oriented projects in biomedicine both financially and through consultation and training programs.

T-cell therapy is a major area of expertise of researchers at the MDC, which carries out basic biomedical research with the aim of understanding the molecular causes of disease and health and translating these findings as quickly as possible into clinical application.
-end-


Max Delbrück Center for Molecular Medicine in the Helmholtz Association

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".